Pharmaceutical use of pyridine compounds

A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAWAKITA, TAKESHI, HAGA, KEIICHIRO, YUTOKU, YUKO, SANO, MITSUHARU, IKEDA, YOSHIFUMI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KAWAKITA
TAKESHI
HAGA
KEIICHIRO
YUTOKU
YUKO
SANO
MITSUHARU
IKEDA
YOSHIFUMI
description A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations. A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5616581A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5616581A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5616581A3</originalsourceid><addsrcrecordid>eNrjZNAIyEgsyk1MTi0tyUxOzFEoLU5VyE9TKKgsykzJzEtVSM7PLcgvzUsp5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFQCPyUkviQ4NNzQzNTC0MHY0JqwAAVrQn-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical use of pyridine compounds</title><source>esp@cenet</source><creator>KAWAKITA; TAKESHI ; HAGA; KEIICHIRO ; YUTOKU; YUKO ; SANO; MITSUHARU ; IKEDA; YOSHIFUMI</creator><creatorcontrib>KAWAKITA; TAKESHI ; HAGA; KEIICHIRO ; YUTOKU; YUKO ; SANO; MITSUHARU ; IKEDA; YOSHIFUMI</creatorcontrib><description>A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations. A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; COMPOSITIONS BASED THEREON ; HETEROCYCLIC COMPOUNDS ; MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS ; METALLURGY ; ORGANIC CHEMISTRY ; ORGANIC MACROMOLECULAR COMPOUNDS ; THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970401&amp;DB=EPODOC&amp;CC=US&amp;NR=5616581A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970401&amp;DB=EPODOC&amp;CC=US&amp;NR=5616581A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAWAKITA; TAKESHI</creatorcontrib><creatorcontrib>HAGA; KEIICHIRO</creatorcontrib><creatorcontrib>YUTOKU; YUKO</creatorcontrib><creatorcontrib>SANO; MITSUHARU</creatorcontrib><creatorcontrib>IKEDA; YOSHIFUMI</creatorcontrib><title>Pharmaceutical use of pyridine compounds</title><description>A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations. A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations.</description><subject>CHEMISTRY</subject><subject>COMPOSITIONS BASED THEREON</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>ORGANIC MACROMOLECULAR COMPOUNDS</subject><subject>THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAIyEgsyk1MTi0tyUxOzFEoLU5VyE9TKKgsykzJzEtVSM7PLcgvzUsp5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFQCPyUkviQ4NNzQzNTC0MHY0JqwAAVrQn-g</recordid><startdate>19970401</startdate><enddate>19970401</enddate><creator>KAWAKITA; TAKESHI</creator><creator>HAGA; KEIICHIRO</creator><creator>YUTOKU; YUKO</creator><creator>SANO; MITSUHARU</creator><creator>IKEDA; YOSHIFUMI</creator><scope>EVB</scope></search><sort><creationdate>19970401</creationdate><title>Pharmaceutical use of pyridine compounds</title><author>KAWAKITA; TAKESHI ; HAGA; KEIICHIRO ; YUTOKU; YUKO ; SANO; MITSUHARU ; IKEDA; YOSHIFUMI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5616581A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1997</creationdate><topic>CHEMISTRY</topic><topic>COMPOSITIONS BASED THEREON</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>ORGANIC MACROMOLECULAR COMPOUNDS</topic><topic>THEIR PREPARATION OR CHEMICAL WORKING-UP</topic><toplevel>online_resources</toplevel><creatorcontrib>KAWAKITA; TAKESHI</creatorcontrib><creatorcontrib>HAGA; KEIICHIRO</creatorcontrib><creatorcontrib>YUTOKU; YUKO</creatorcontrib><creatorcontrib>SANO; MITSUHARU</creatorcontrib><creatorcontrib>IKEDA; YOSHIFUMI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAWAKITA; TAKESHI</au><au>HAGA; KEIICHIRO</au><au>YUTOKU; YUKO</au><au>SANO; MITSUHARU</au><au>IKEDA; YOSHIFUMI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical use of pyridine compounds</title><date>1997-04-01</date><risdate>1997</risdate><abstract>A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations. A pyridine compound of the formula (I) wherein R1 is a hydrogen, a halogen, an alkyl, an alkoxy or the like, R2 and R3 are each a hydrogen, a halogen or an alkyl, -P=Q- is -CH=CH-, -N=CH- or -CH=N-, A is an oxygen atom, a sulfur atom or N(R4) wherein R4 is hydrogen, alkyl or the like, n is 0, 1 or 2, B is S(O)p wherein p is 0, 1 or 2, D is a single bond, an alkylene or the like and E is an alkoxyalkyl or -N(R6)(R7), and a pharmaceutically acceptable salt thereof have antibacterial activity against Helicobacter pylori, antiulcer activity, gastrointestinal cytoprotective activity, ulcer recurrence, relapse-preventive activity and gastric acid secretion-suppressive activity and are useful as pharmaceutical preparations.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US5616581A
source esp@cenet
subjects CHEMISTRY
COMPOSITIONS BASED THEREON
HETEROCYCLIC COMPOUNDS
MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
METALLURGY
ORGANIC CHEMISTRY
ORGANIC MACROMOLECULAR COMPOUNDS
THEIR PREPARATION OR CHEMICAL WORKING-UP
title Pharmaceutical use of pyridine compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A23%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAWAKITA;%20TAKESHI&rft.date=1997-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5616581A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true